Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2022-03-15 Tax Withholding | 2022-03-17 5:56 pm | N/A N/A | Revance Therapeutics Inc. | RVNC | Joshi Abhay COO, President of R&D | 2,607 | $15.79 | 120,708 (Direct) | View |
| 2022-02-15 Tax Withholding | 2022-02-17 8:51 pm | N/A N/A | Revance Therapeutics Inc. | RVNC | Joshi Abhay COO, President, R&D | 5,053 | $13.35 | 123,315 (Direct) | View |
| 2021-03-15 Tax Withholding | 2021-03-17 7:27 pm | N/A N/A | Revance Therapeutics Inc. | RVNC | Joshi Abhay COO, President, R&D | 1,354 | $27.73 | 128,368 (Direct) | View |
| 2021-02-15 Tax Withholding | 2021-02-19 8:10 pm | N/A N/A | Revance Therapeutics Inc. | RVNC | Joshi Abhay COO, President, R&D | 4,848 | $28.97 | 129,722 (Direct) | View |
| 2021-02-02 Option Award | 2021-02-04 9:16 pm | N/A 2031-02-01 | Revance Therapeutics Inc. | RVNC | Joshi Abhay COO, President, R&D | 63,545 | $0 | 175,495 (Direct) | View |
| 2020-09-30 Option Award | 2020-10-02 8:31 pm | N/A N/A | Revance Therapeutics Inc. | RVNC | Joshi Abhay COO, President, R&D | 17,500 | $0 | 111,950 (Direct) | View |
| 2020-09-30 Tax Withholding | 2020-10-02 8:31 pm | N/A N/A | Revance Therapeutics Inc. | RVNC | Joshi Abhay COO, President, R&D | 7,382 | $25.14 | 111,950 (Direct) | View |
| 2020-03-15 Tax Withholding | 2020-03-17 8:34 pm | N/A N/A | Revance Therapeutics Inc. | RVNC | Joshi Abhay COO, President of R&D | 1,354 | $15.5 | 101,832 (Direct) | View |
| 2020-02-15 Tax Withholding | 2020-02-19 8:22 pm | N/A N/A | Revance Therapeutics Inc. | RVNC | Joshi Abhay COO, President, R&D | 3,325 | $25.33 | 103,186 (Direct) | View |
| 2020-01-23 Option Award | 2020-01-24 8:16 pm | N/A 2030-01-22 | Revance Therapeutics Inc. | RVNC | Joshi Abhay Chief Operating Officer | 171,500 | $0 | 253,011 (Direct) | View |
| 2020-01-15 Tax Withholding | 2020-01-17 8:12 pm | N/A N/A | Revance Therapeutics Inc. | RVNC | Joshi Abhay Chief Operating Officer | 4,441 | $22.89 | 81,511 (Direct) | View |